NCT05085886

Brief Summary

The purpose of this study is to examine the effectiveness of a multi-level intervention - centered around a web-application that facilitates depression screening, automated shared decision making (SDM), patient activation, and psychoeducation - on mental health treatment optimization among patients with elevated depressive symptoms with or without co-morbid anxiety receiving care in primary care clinics that offer collaborative care. The objectives of the study include: Leveraging user centered design to refine a strategy centered around an electronic SDM (eSDM) tool (aim 1), and assessing the effect of the strategy on provider behavior (aim 2) and on patient enrollment in depression treatment (aim 3).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
605

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 3, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 20, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

1.9 years

First QC Date

September 28, 2021

Last Update Submit

February 12, 2025

Conditions

Keywords

collaborative careimplementation scienceElevated Depressive Symptoms

Outcome Measures

Primary Outcomes (1)

  • Total proportion of patients who initiate or optimize depression treatment

    The proportion of patients who initiate or optimize depression treatment, defined as those with at least 1 mental health visit or antidepressant fill during the 4 months following enrollment. Hypothesis 1: this proportion will be greater for patients of providers in the DepCare arm than for the Enhanced Usual Care arm

    During 4 months post-index visit

Secondary Outcomes (5)

  • Proportion of patients whose providers take action to optimize depression treatment

    Baseline

  • Change in proportion of patients receiving any depression treatment

    4 months pre-Index Visit, 4 months post-index visit

  • Proportion of patients with at least 2 mental health visits

    During 6 months post-index visit

  • Proportion of patients with at least 2 antidepressant fills

    During 6 months post-index visit

  • Mean decisional conflict scale

    Baseline

Study Arms (2)

DepCare Intervention

EXPERIMENTAL

The clinic (administrators, staff, care managers) will receive quality improvement support and education around depression screening as well as local technical assistance for mental health treatment optimization. The cluster of primary care providers in the intervention arm will receive education and decisional support for optimizing mental health treatment and access to quality improvement/implementation meetings. When feasible, eligible patients will receive a tool that facilitates enhanced screening, diagnosis recognition, treatment selection support, psychoeducation, and activation.

Behavioral: DepCareBehavioral: Enhanced Usual Care

Enhanced Usual Care

ACTIVE COMPARATOR

The clinic (administrators, staff, care managers) will receive quality improvement support and education around depression screening as well as local technical assistance for mental health treatment optimization. The cluster of primary care providers and patients in the active comparator arm will have access to this clinic-level strategy (i.e., the same clinic level intervention as in the DepCare group), but will not receive any provider or patient-level interventions.

Behavioral: Enhanced Usual Care

Interventions

DepCareBEHAVIORAL

Primary Care Provider (1) One-time presentation or video with education and motivational messaging around collaborative care, functionality of the DepCare patient tool and optimal management of depression and comorbid anxiety (2) Quality improvement/ implementation team meetings on optimizing mental health treatment in primary care and DepCare (i.e., multi-level, multi-component intervention) implementation (3) Automatically-generated decisional support on individual patient treatment preferences (i.e., for every patient who receives the DepCare patient tool) Patient: Tool comprised of enhanced depression and anxiety screening (includes option for voice-over questions, point-and-click responses), and for those who screen positive for depressive symptoms (with or without comorbid anxiety), diagnosis recognition support, psycho-education, videos promoting patient engagement in treatment, and personalized medication selection support.

DepCare Intervention

Clinic-level (1) Quality Improvement Support and education around valid depression screening (2) Local technical support for mental health treatment optimization

DepCare InterventionEnhanced Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English or Spanish Speaking
  • ≥ 18 years of age
  • Elevated depressive symptoms Elevated Patient Health Questionnaire (PHQ)-9 \>=10 Elevated PHQ-9 \>=5 and Generalized Anxiety Disorder (GAD)-7 \>= 10

You may not qualify if:

  • Under the care of a psychiatrist or depression collaborative care manager in the prior 3 months
  • Diagnosis of psychosis or schizophrenia
  • Diagnosis of bipolar disorder
  • Dementia or severe cognitive impairment
  • History of coronary heart disease
  • Pregnancy
  • Dementia or severe cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center/New York Presbyterian Hospital

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Nathalie Moise, MD, MS

    Florence Assistant Professor of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Treatment optimization assessor will be blinded to intervention vs. control start arm of the intervention.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: 2 arm design with provider being the unit of randomization and patients being nested within provider
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine, Dept of Medicine

Study Record Dates

First Submitted

September 28, 2021

First Posted

October 20, 2021

Study Start

August 3, 2021

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Upon request, we plan to make available a deidentified database that includes PHQ data, patient engagement, optimization, demographics and comorbidity characteristics of patients in our study Study protocol statistical analysis plan Analytic code. Within 1 year of publication of trial primary outcome results

Time Frame
Within 1 year of publication of trial primary outcome results
Access Criteria
de-identified database

Locations